However, fewer than 50% of those eligible is receiving treatment to reduce the risk of experiencing another

heart attack – secondary prevention – according to the World Health Organization, even though this is

generally low cost.6

VEEVA: Z4-8447 | Date of preparation: January 2018 | Date of expiry: January 2019 | For use with medical, trade and consumer media | Before use with media, this document will require local review and Nom Sig approval

Secondary Prevention in Myocardial Infarction

There are ways to reduce the risk of secondary CV events, including MI; quitting tobacco, eating

a healthy diet, and being physically active are beneficial, as are treatments for other risk factors

such as blood pressure and cholesterol, for which there are a variety of medical therapies.6,7,8

Myocardial infarction (MI), or heart attack, occurs when the blood supply to the heart is suddenly blocked. Lack of blood to the heart can cause damage to the heart muscle and may be life-threatening.1 MI is a serious health problem with an estimated 7million

MIs a year.2

Those who experience an MI are at significant risk of a subsequent cardiovascular (CV) event within

In a review of the medical records of more than 4,000 people with a median age of 74, who had experienced a heart attack and who also had chronic health problems such as diabetes, kidney disease or heart failure,

REFERENCES: | 1. NHS Choices. Heart attack. Available at: http://www.nhs.uk/conditions/Heart-attack/Pages/ Introduction.aspx Last accessed: June 2017. 2. White HD, Chew DP. Acute myocardial infarction. Lancet. 2008;372:570-84. 3. Johansson A, Rosdengren A, Young K et al. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review. BMC Cardiovasc Disord. 2017; 17: 53. 4. Varenhorst C, Hasvold P, Johansson S et al. Culprit and nonculprit recurrent ischemic events in patients with myocardial infarction: Data from SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence‐Based Care in Heart Disease Evaluated According to Recommended Therapies). J Am Heart Assoc. 2018;7:e007174. 5.Rapsomaniki E, Stogiannis D, Emmas C, et al. Health outcomes in patients with stable coronary artery disease following myocardial infarction; construction of a PEGASUS-TIMI-54 like population in UK linked electronic health records Eur Heart J, 2014;35(Suppl.1):363 (abstract P2077). 6. World Health Organization. Prevention of Recurrences of Myocardial Infarction and Stroke Study. Available at: http://www.who.int/cardiovascular_ diseases/priorities/secondary_prevention/country/en/ Last accessed: June 2017. 7. National Institute for Health and Care Excellence. Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease (CG172). 13 November 2013. Available at: https://www.nice.org.uk/guidance/cg172/resources/myocardial-infarction-cardiac-rehabilitation-and-prevention-of-further-cardiovascular-disease-pdf-35109748874437 Last accessed July 2017. 8. Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update. Circulation. 2011;124:2458-2473.

up to 1 in 6people

went on to experience another MI, stroke or death in the following 3 years.5

of the attack,3 and a real-world study of 100,000+ MI survivors found that the risk of another MI was persistent, even if they had received treatment at the time of their initial MI.4

12 months